Who Paid My Doc
CB100 Dose Comparison Study
Research payments
$7,153,812
Through program year 2024, $7,153,812 in research payments was reported against CB100 Dose Comparison Study, across 110 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $2,295,653 | 28 |
| 2023 | Research | $2,940,745 | 32 |
| 2022 | Research | $1,917,414 | 50 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Krauss Ann Arbor, MI Named on 6 payments
- Grace Dy Buffalo, NY Named on 6 payments
- John Strickler Durham, NC Named on 4 payments
- Kartik Konduri Dallas, TX Named on 4 payments
- Bob Li New York, NY Named on 4 payments
- David Hong Houston, TX Named on 4 payments
- Gregory Durm Indianapolis, IN Named on 3 payments
- Ramaswamy Govindan Saint Louis, MO Named on 3 payments
- Afshin Dowlati Cleveland, OH Named on 3 payments
- Ignacio Garrido-Laguna Salt Lake City, UT Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.